Latest Aggregates News

Adavale Resources plans a significant 20:1 share consolidation to streamline its capital structure and attract institutional investors, coinciding with promising exploration progress at its Parkes Gold and Copper Project.

Dateline Resources Limited has updated its scoping study for the Colosseum Gold Project in California, incorporating a revised gold price of US$2,900/oz that significantly enhances the project's economic outlook. The study confirms robust project fundamentals and sets the stage for a Definitive Feasibility Study.

Monadelphous Group Limited has landed a suite of new contracts worth approximately $180 million across Western Australia's resources, energy, and infrastructure sectors, reinforcing its strong foothold in the region.

Fletcher Building is dissolving its Australian Division, folding operations into two new trans-Tasman units, while targeting $15 million in annual cost savings as market challenges persist.

Aristocrat Leisure Limited reported a robust HY25 with revenue rising 9% to AUD 3 billion and a 6% increase in NPATA, underpinned by strategic acquisitions and operational resilience. The company signals confidence in sustained growth through innovation and market expansion.

Credit Corp Group maintains its FY25 NPAT guidance amid operational gains in US debt buying and cautious optimism in Australian/New Zealand lending markets.

Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.

Eden Innovations has secured its inaugural order from Holcim Mexico for EdenCretePz7, marking a strategic expansion into a major new market and extending its footprint within the global Holcim Group.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.

Alterity Therapeutics has secured FDA Fast Track designation for ATH434, its lead candidate for treating Multiple System Atrophy, potentially speeding up regulatory review and bringing hope to patients with this rare neurodegenerative disorder.

Macro Metals Limited has secured $2 million from a strategic placement to Paramount Earthmoving, advanced exploration across multiple Pilbara projects, and entered a second majority Indigenous-owned joint venture, positioning itself for growth in mining services.

Jayride Group has appointed a new management team and raised $1.51 million to fund a major restructuring focused on halving operating costs and resolving supplier payment issues. Despite supply constraints, demand remains strong, positioning the company for a potential rebound.